Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2017-07-31 to 2022-02-07
Current total value of award: $27.95
Description: 8504617050!LORAZEPAM INJECTION